TNK BIOTECH ApS
CVR 30691911 · Private limited company (ApS) · Active · Medium risk
TNK BIOTECH ApS is a Private limited company (ApS), founded on , based in Kgs. Lyngby. The company is registered in the industry investering for egen regning. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 19 annual reports have been published, of which 5 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -82k and a net result of DKK -18k. CEO: Thomas Nitschke Kledal.
Bankruptcy risk for TNK BIOTECH ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 30691911
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (19 years)
- Address
- Asylgade 7A
2800 Kgs. Lyngby - Municipality
- Lyngby-Taarbæk
- Industry
- Investering for egen regning (649910)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 125k
- Employees
- 0 (2013)
- Auditor
- DANSK REVISION ROSKILDE, GODKENDT REVISIONSAKTIESELSKAB
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 5 of 19 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -305.9% |
| Current ratio | 6% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -11k | DKK -11k |
| Net profit | DKK -18k | DKK -16k |
| Equity | DKK -82k | DKK -65k |
| Total assets | DKK 27k | DKK 41k |
| Cash | DKK 6,855 | – |
| Short-term debt | DKK 109k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · DANSK REVISION ROSKILDE, GODKENDT REVISIONSAKTIESELSKAB.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 194 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 189 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 191 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 178 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 190 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 268 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 165 | ||
| 1 Jan 2017 – 31 Dec 2017 | 163 | ||
| 1 Jan 2016 – 31 Dec 2016 | 167 | ||
| 1 Jan 2015 – 31 Dec 2015 | 169 | ||
| 1 Jan 2014 – 31 Dec 2014 | 173 | ||
| 1 Jan 2013 – 31 Dec 2013 | 168 | ||
| 1 Jan 2012 – 31 Dec 2012 | 170 | ||
| 1 Jan 2011 – 31 Dec 2011 | 171 | ||
| 1 Jan 2010 – 31 Dec 2010 | 179 | ||
| 1 Jan 2009 – 31 Dec 2009 | 152 | ||
| 1 Jan 2008 – 31 Dec 2008 | 155 | ||
| 25 Jun 2007 – 31 Dec 2007 | 171 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Thomas Nitschke Kledal | Current | |
| Owner (100%) | Thomas Nitschke Kledal | Current | |
| Auditor | GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | DANSK REVISION ROSKILDE, GODKENDT REVISIONSAKTIESELSKAB | ||
| Founder | Thomas Nitschke Kledal | Current |
The CEOs' other companies
Thomas Nitschke Kledal – 6 other companies, of which 1 bankrupt
- KORTKOMPAGNIET ApS Bankrupt 6 Mar 2015
- CO2 BALANCE A/S Active
- CRITHERAPY ApS Compulsorily dissolved
- INAGEN ApS Opløst
- SYNKLINO A/S Active
- TOGL INVEST ApS Opløst
Address history (2 moves)
| Asylgade 7A, 2800 Kgs. Lyngby | |
| Asylgade 7A, 2800 Kgs.Lyngby | |
| Sønderskovvej 20, 4180 Sorø |
Former names
| TNK BIOTECH ApS | – now |
| TNK INVEST ApS | – |
Employees per year
Other companies at the same address
- DOCULOGIC ApS Opløst
- INAGEN ApS Opløst
Similar companies in Lyngby-Taarbæk
- ApS SPKR NR. 1116 Kgs.Lyngby
- AJ ADVICE OG INVEST AF 1994 ApS Kgs. Lyngby
- NORDAN INVESTMENT ApS Virum
- ROSAMUNDE ApS Klampenborg
- XENIA ApS Kgs. Lyngby
- B S-AIRCONDITION ApS Kgs.Lyngby
- HESAMA INVEST ApS Virum
- SFB DENMARK A/S Kgs. Lyngby
- COBRA INVEST 1974 A/S Kongens Lyngby
- Helms & Sams Natur ApS Kongens Lyngby
- Tofteng Holding ApS Kongens Lyngby
- Tofteng Holding 2026 ApS Kongens Lyngby
Questions and answers about TNK BIOTECH ApS
Has TNK BIOTECH ApS gone bankrupt?
No, TNK BIOTECH ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of TNK BIOTECH ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of TNK BIOTECH ApS?
Thomas Nitschke Kledal is the CEO of TNK BIOTECH ApS.
Who is the auditor of TNK BIOTECH ApS?
TNK BIOTECH ApS most recently used DANSK REVISION ROSKILDE, GODKENDT REVISIONSAKTIESELSKAB.
When was TNK BIOTECH ApS founded?
TNK BIOTECH ApS was founded on 25 June 2007.
What is the equity of TNK BIOTECH ApS?
Equity was DKK -82k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.